{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:06:46Z","timestamp":1773666406155,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Traditional Chinese Medicine and Ethnic Medicine of Guizhou Provincial Administration of Traditional Chinese Medicine","award":["QZYY-2025-083"],"award-info":[{"award-number":["QZYY-2025-083"]}]},{"name":"Medical Research Union Found for High-quality health development of Guizhou Province","award":["2024GZYXKYJJXM0149"],"award-info":[{"award-number":["2024GZYXKYJJXM0149"]}]},{"name":"Key Laboratory for Cancer Prevention and treatment of Guizhou Province","award":["QKHPT[2025]031"],"award-info":[{"award-number":["QKHPT[2025]031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04241-6","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:53:12Z","timestamp":1770688392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Programmed cell death inhibitors: a new hope for cancer therapy?"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuting","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qirun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixue","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"4241_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12943-024-02172-y","volume":"23","author":"R He","year":"2024","unstructured":"He R, Liu Y, Fu W, He X, Liu S, Xiao D, Tao Y. Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression. Mol Cancer. 2024;23:267.","journal-title":"Mol Cancer"},{"key":"4241_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41586-020-2129-8","volume":"580","author":"H Jiao","year":"2020","unstructured":"Jiao H, Wachsmuth L, Kumari S, Schwarzer R, Lin J, Eren RO, Fisher A, Lane R, Young GR, Kassiotis G, et al. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature. 2020;580:391\u20135.","journal-title":"Nature"},{"key":"4241_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1415","volume":"4","author":"J Vakkila","year":"2004","unstructured":"Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004;4:641\u20138.","journal-title":"Nat Rev Immunol"},{"key":"4241_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-025-01726-x","volume":"18","author":"J Tang","year":"2025","unstructured":"Tang J, Zhuang Y, Zhang Y, Hu H, Wang H, Xu H, Li Y, Tu C. Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. J Hematol Oncol. 2025;18:77.","journal-title":"J Hematol Oncol"},{"key":"4241_CR5","first-page":"3174","volume":"5","author":"ZY Liu","year":"2015","unstructured":"Liu ZY, Wu B, Guo YS, Zhou YH, Fu ZG, Xu BQ, Li JH, Jing L, Jiang JL, Tang J, Chen ZN. Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice. Am J Cancer Res. 2015;5:3174\u201385.","journal-title":"Am J Cancer Res"},{"key":"4241_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature19076","volume":"536","author":"B Strilic","year":"2016","unstructured":"Strilic B, Yang L, Albarran-Juarez J, Wachsmuth L, Han K, Muller UC, Pasparakis M, Offermanns S. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature. 2016;536:215\u20138.","journal-title":"Nature"},{"key":"4241_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41419-019-1735-6","volume":"10","author":"J Hou","year":"2019","unstructured":"Hou J, Ju J, Zhang Z, Zhao C, Li Z, Zheng J, Sheng T, Zhang H, Hu L, Yu X, et al. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis. Cell Death Dis. 2019;10:493.","journal-title":"Cell Death Dis"},{"key":"4241_CR8","doi-asserted-by":"publisher","first-page":"10683","DOI":"10.1038\/s41467-024-55006-2","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu X, Lu D, Qi X, Paudel RR, Lin H, Holloman BL, Jin F, Xu L, Ding L, Peng W, et al. Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024;15:10683.","journal-title":"Nat Commun"},{"key":"4241_CR9","doi-asserted-by":"crossref","unstructured":"Amor\u00f3s Morales LC, G\u00f3mez Bergna SM, Marchesini A, Scalise ML, Gonzalez N, Ferrelli ML, Candolfi M, Romanowski V, Pidre ML. RIPK1 in diffuse glioma pathology: from prognosis marker to potential therapeutic target. Int J Mol Sci 2025, 26.","DOI":"10.3390\/ijms26125555"},{"key":"4241_CR10","doi-asserted-by":"publisher","first-page":"22219","DOI":"10.18632\/oncotarget.7924","volume":"7","author":"X Liu","year":"2016","unstructured":"Liu X, Zhou M, Mei L, Ruan J, Hu Q, Peng J, Su H, Liao H, Liu S, Liu W, et al. Key roles of necroptotic factors in promoting tumor growth. Oncotarget. 2016;7:22219\u201333.","journal-title":"Oncotarget"},{"key":"4241_CR11","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","volume":"15","author":"CY Liao","year":"2024","unstructured":"Liao CY, Li G, Kang FP, Lin CF, Xie CK, Wu YD, Hu JF, Lin HY, Zhu SC, Huang XX, et al. Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Nat Commun. 2024;15:6043.","journal-title":"Nat Commun"},{"key":"4241_CR12","doi-asserted-by":"publisher","first-page":"e13406","DOI":"10.1111\/imr.13406","volume":"329","author":"A Pandey","year":"2025","unstructured":"Pandey A, Li Z, Gautam M, Ghosh A, Man SM. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis. Immunol Rev. 2025;329:e13406.","journal-title":"Immunol Rev"},{"key":"4241_CR13","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","volume":"11","author":"BE Burdette","year":"2021","unstructured":"Burdette BE, Esparza AN, Zhu H, Wang S. Gasdermin D in pyroptosis. Acta Pharm Sin B. 2021;11:2768\u201382.","journal-title":"Acta Pharm Sin B"},{"key":"4241_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20:143\u201357.","journal-title":"Nat Rev Immunol"},{"key":"4241_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang M, Qi L, Li L, Li Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 2020;6:112.","journal-title":"Cell Death Discov"},{"key":"4241_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12943-025-02506-4","volume":"24","author":"A Alishvandi","year":"2025","unstructured":"Alishvandi A, Aram C, Shahrivar FF, Kesharwani P, Sahebkar A. Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression. Mol Cancer. 2025;24:297.","journal-title":"Mol Cancer"},{"key":"4241_CR17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41423-024-01231-0","volume":"21","author":"S Chen","year":"2024","unstructured":"Chen S, Zhang P, Zhu G, Wang B, Cai J, Song L, Wan J, Yang Y, Du J, Cai Y, et al. Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma. Cell Mol Immunol. 2024;21:1505\u201321.","journal-title":"Cell Mol Immunol"},{"key":"4241_CR18","doi-asserted-by":"publisher","first-page":"1626311","DOI":"10.3389\/fimmu.2025.1626311","volume":"16","author":"G Kahaer","year":"2025","unstructured":"Kahaer G, Pan S, Yang C, Xie W, Lu Y. Dual function of gasdermin E: pyroptosis-mediated pan-cancer suppression versus HCC-specific oncogenic activity. Front Immunol. 2025;16:1626311.","journal-title":"Front Immunol"},{"key":"4241_CR19","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu JM, Nie L, Chen Y, Wang YC, Liu C, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22:1264\u201375.","journal-title":"Nat Cell Biol"},{"key":"4241_CR20","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1158\/1078-0432.CCR-18-2381","volume":"25","author":"\u00c1 Molina-Crespo","year":"2019","unstructured":"Molina-Crespo \u00c1, Cadete A, Sarrio D, G\u00e1mez-Chiachio M, Martinez L, Chao K, Olivera A, Gonella A, D\u00edaz E, Palacios J, et al. Intracellular delivery of an antibody targeting Gasdermin-B reduces HER2 breast cancer aggressiveness. Clin Cancer Res. 2019;25:4846\u201358.","journal-title":"Clin Cancer Res"},{"key":"4241_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1182\/blood-2016-01-694117","volume":"128","author":"JP Nicolay","year":"2016","unstructured":"Nicolay JP, M\u00fcller-Decker K, Schroeder A, Brechmann M, M\u00f6bs M, G\u00e9raud C, Assaf C, Goerdt S, Krammer PH, G\u00fclow K. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-\u03baB. Blood. 2016;128:805\u201315.","journal-title":"Blood"},{"key":"4241_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1182\/blood.2022018669","volume":"142","author":"JP Nicolay","year":"2023","unstructured":"Nicolay JP, Melchers S, Albrecht JD, Assaf C, Dippel E, Stadler R, Wehkamp U, Wobser M, Zhao J, Burghaus I, et al. Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study. Blood. 2023;142:794\u2013805.","journal-title":"Blood"},{"key":"4241_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41419-025-07412-7","volume":"16","author":"Y Dai","year":"2025","unstructured":"Dai Y, Li H, Fan S, Wang K, Cui Z, Zhao X, Sun X, Lin M, Li J, Gao Y, et al. Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma. Cell Death Dis. 2025;16:71.","journal-title":"Cell Death Dis"},{"key":"4241_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12929-025-01187-x","volume":"32","author":"H Jiang","year":"2025","unstructured":"Jiang H, Liu L, He S, Qu S, Yang Y, Kang G, Wu M, Liu H, Zhang Y, Wang Z, et al. Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor immunity by activating mtDNA-cGAS-STING pathway. J Biomed Sci. 2025;32:92.","journal-title":"J Biomed Sci"},{"key":"4241_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-025-02295-8","volume":"10","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Xiang Z, Xu Y, Cheung LS, Wang X, Wang M, Wong HHW, Zhu Z, Zhang W, Gao Y, et al. Oleic acid restores the impaired antitumor immunity of \u03b3\u03b4-T cells induced by palmitic acid. Signal Transduct Target Ther. 2025;10:209.","journal-title":"Signal Transduct Target Ther"},{"key":"4241_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, et al. FDA-approved Disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21:736\u201345.","journal-title":"Nat Immunol"},{"key":"4241_CR27","doi-asserted-by":"publisher","first-page":"112648","DOI":"10.1016\/j.yexcr.2021.112648","volume":"405","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wei K. Necrosulfonamide reverses pyroptosis-induced Inhibition of proliferation and differentiation of osteoblasts through the NLRP3\/caspase-1\/GSDMD pathway. Exp Cell Res. 2021;405:112648.","journal-title":"Exp Cell Res"},{"key":"4241_CR28","doi-asserted-by":"publisher","first-page":"e32571","DOI":"10.1016\/j.heliyon.2024.e32571","volume":"10","author":"F Chen","year":"2024","unstructured":"Chen F, Tang H, Lin J, Kang R, Tang D, Liu J. Ciprofloxacin is a novel anti-ferroptotic antibiotic. Heliyon. 2024;10:e32571.","journal-title":"Heliyon"},{"key":"4241_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41420-025-02516-7","volume":"11","author":"N Miao","year":"2025","unstructured":"Miao N, Kang Z, Wang Z, Yu W, Liu T, Kong LZ, Zheng Y, Ding C, Zhang Z, Zhong C, et al. Mitochondrial reactive oxygen species promote cancer metastasis and tumor microenvironment immunosuppression through gasdermin D. Cell Death Discov. 2025;11:219.","journal-title":"Cell Death Discov"},{"key":"4241_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4241_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"4241_CR32","doi-asserted-by":"publisher","first-page":"595498","DOI":"10.3389\/fphar.2020.595498","volume":"11","author":"AM Johnson","year":"2020","unstructured":"Johnson AM, Kleczko EK, Nemenoff RA. Eicosanoids in cancer: new roles in immunoregulation. Front Pharmacol. 2020;11:595498.","journal-title":"Front Pharmacol"},{"key":"4241_CR33","doi-asserted-by":"publisher","first-page":"eadk1200","DOI":"10.1126\/sciadv.adk1200","volume":"10","author":"Q Huang","year":"2024","unstructured":"Huang Q, Ru Y, Luo Y, Luo X, Liu D, Ma Y, Zhou X, Linghu M, Xu W, Gao F, Huang Y. Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Sci Adv. 2024;10:eadk1200.","journal-title":"Sci Adv"},{"key":"4241_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41401-024-01378-6","volume":"46","author":"PX Deng","year":"2025","unstructured":"Deng PX, Silva M, Yang N, Wang Q, Meng X, Ye KQ, Gao HC, Zheng WH. Artemisinin inhibits neuronal ferroptosis in alzheimer\u2019s disease models by targeting KEAP1. Acta Pharmacol Sin. 2025;46:326\u201337.","journal-title":"Acta Pharmacol Sin"},{"key":"4241_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, Wang Q, Yang M, Qian J, Yi Q. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u2013e10121005.","journal-title":"Cell Metab"},{"key":"4241_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"4241_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.molcel.2024.11.013","volume":"85","author":"Q Liao","year":"2025","unstructured":"Liao Q, Deng J, Tong J, Gan Y, Hong W, Dong H, Cao M, Xiong C, Chen Y, Xie B, et al. p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and Cuproptosis. Mol Cell. 2025;85:132\u2013e149137.","journal-title":"Mol Cell"},{"key":"4241_CR38","doi-asserted-by":"crossref","unstructured":"Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, Huo D, Wu S, Alapati A, Aggarwal S et al. Radiotherapy promotes Cuproptosis and synergizes with Cuproptosis inducers to overcome tumor radioresistance. Cancer Cell 2025.","DOI":"10.1016\/j.ccell.2025.03.031"},{"key":"4241_CR39","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1039\/D2TB01150F","volume":"10","author":"Y Lu","year":"2022","unstructured":"Lu Y, Pan Q, Gao W, Pu Y, He B. Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via Cuproptosis. J Mater Chem B. 2022;10:6296\u2013306.","journal-title":"J Mater Chem B"},{"key":"4241_CR40","doi-asserted-by":"publisher","first-page":"1209156","DOI":"10.3389\/fonc.2023.1209156","volume":"13","author":"X Tang","year":"2023","unstructured":"Tang X, Yan Z, Miao Y, Ha W, Li Z, Yang L, Mi D. Copper in cancer: from limiting nutrient to therapeutic target. Front Oncol. 2023;13:1209156.","journal-title":"Front Oncol"},{"key":"4241_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12964-025-02135-w","volume":"23","author":"X Huang","year":"2025","unstructured":"Huang X, Yan H, Xu Z, Yang B, Luo P, He Q. The inducible role of autophagy in cell death: emerging evidence and future perspectives. Cell Commun Signal. 2025;23:151.","journal-title":"Cell Commun Signal"},{"key":"4241_CR42","doi-asserted-by":"publisher","first-page":"102821","DOI":"10.1016\/j.arr.2025.102821","volume":"110","author":"ELP Ramos","year":"2025","unstructured":"Ramos ELP, Sousa Neto IV, Pinto AP, Cintra DE, Ropelle ER, Pauli JR, de Freitas EC, Mineo TWP, da Silva ASR. Mechanisms underlying the interplay between autophagy and the inflammasome in age-related diseases: implications for exercise immunology. Ageing Res Rev. 2025;110:102821.","journal-title":"Ageing Res Rev"},{"key":"4241_CR43","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tcb.2025.01.010","volume":"35","author":"X Huang","year":"2025","unstructured":"Huang X, Zhang J, Yao J, Mi N, Yang A. Phase separation of p62: roles and regulations in autophagy. Trends Cell Biol. 2025;35:854\u201365.","journal-title":"Trends Cell Biol"},{"key":"4241_CR44","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4241_CR45","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.molcel.2022.03.023","volume":"82","author":"GA Hernandez","year":"2022","unstructured":"Hernandez GA, Perera RM. Autophagy in cancer cell remodeling and quality control. Mol Cell. 2022;82:1514\u201327.","journal-title":"Mol Cell"},{"key":"4241_CR46","doi-asserted-by":"publisher","first-page":"e838","DOI":"10.1038\/cddis.2013.350","volume":"4","author":"X Sui","year":"2013","unstructured":"Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838.","journal-title":"Cell Death Dis"},{"key":"4241_CR47","doi-asserted-by":"publisher","first-page":"105582","DOI":"10.1016\/j.phrs.2021.105582","volume":"168","author":"PMP Ferreira","year":"2021","unstructured":"Ferreira PMP, Sousa RWR, Ferreira JRO, Milit\u00e3o GCG, Bezerra DP. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res. 2021;168:105582.","journal-title":"Pharmacol Res"},{"key":"4241_CR48","doi-asserted-by":"crossref","unstructured":"Gong C, Lin Q, Qin T, Zeng Y, Xu F, Yang Y, Yin D, Duan Z, Chen CL, Wing-Cheong Chow L et al. Targeting autophagy plus high-dose CDK4\/6 inhibitors in advanced HR+HER2- breast cancer: A phase 1b\/2 trial. Med 2024:100559.","DOI":"10.1016\/j.medj.2024.11.012"},{"key":"4241_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-025-03320-y","volume":"44","author":"Y Cui","year":"2025","unstructured":"Cui Y, Cao X, Zhang Y, Fu C, Li D, Sun Y, Zhang Y, Xu T, Tsukamoto T, Cao D, Jiang J. Protein phosphatase 1 regulatory subunit 15 A (PPP1R15A) promoted the progression of gastric cancer by activating cell autophagy under energy stress. J Exp Clin Cancer Res. 2025;44:52.","journal-title":"J Exp Clin Cancer Res"},{"key":"4241_CR50","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3892\/ijo.2014.2313","volume":"44","author":"S Shao","year":"2014","unstructured":"Shao S, Li S, Qin Y, Wang X, Yang Y, Bai H, Zhou L, Zhao C, Wang C. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. Int J Oncol. 2014;44:1661\u20138.","journal-title":"Int J Oncol"},{"key":"4241_CR51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/iub.2816","volume":"76","author":"SM Elgendy","year":"2024","unstructured":"Elgendy SM, Zaher DM, Sarg NH, Abu Jayab NN, Alhamad DW, Al-Tel TH, Omar HA. Autophagy Inhibition potentiates energy restriction-induced cell death in hepatocellular carcinoma cells. IUBMB Life. 2024;76:577\u201388.","journal-title":"IUBMB Life"},{"key":"4241_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s13555-024-01097-0","volume":"14","author":"VJ Ludbrook","year":"2024","unstructured":"Ludbrook VJ, Budd DC, Thorn K, Tompson D, Votta BJ, Walker L, Lee A, Chen X, Peppercorn A, Loo WJ. Inhibition of Receptor-Interacting protein kinase 1 in chronic plaque psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled study. Dermatol Ther (Heidelb). 2024;14:489\u2013504.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"4241_CR53","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cpt.1852","volume":"108","author":"K Weisel","year":"2020","unstructured":"Weisel K, Berger S, Papp K, Maari C, Krueger JG, Scott N, Tompson D, Wang S, Simeoni M, Bertin J, Peter Tak P. Response to Inhibition of Receptor-Interacting protein kinase 1 (RIPK1) in active plaque psoriasis: A randomized Placebo-Controlled study. Clin Pharmacol Ther. 2020;108:808\u201316.","journal-title":"Clin Pharmacol Ther"},{"key":"4241_CR54","doi-asserted-by":"crossref","unstructured":"Weisel K, Scott N, Berger S, Wang S, Brown K, Powell M, Broer M, Watts C, Tompson DJ, Burriss SW et al. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterol 2021, 8.","DOI":"10.1136\/bmjgast-2021-000680"},{"key":"4241_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13075-021-02468-0","volume":"23","author":"K Weisel","year":"2021","unstructured":"Weisel K, Berger S, Thorn K, Taylor PC, Peterfy C, Siddall H, Tompson D, Wang S, Quattrocchi E, Burriss SW, et al. A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis. Arthritis Res Ther. 2021;23:85.","journal-title":"Arthritis Res Ther"},{"key":"4241_CR56","doi-asserted-by":"crossref","unstructured":"Braley TJ, Huber AK, Segal BM, Kaplish N, Saban R, Washnock-Schmid JM, Chervin RD. A randomized, subject and rater-blinded, placebo-controlled trial of dimethyl fumarate for obstructive sleep apnea. Sleep 2018, 41.","DOI":"10.1093\/sleep\/zsy109"},{"key":"4241_CR57","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani D, Berisa M, Tavarez DA, Li Z, Miele M, Bai Y, Lee SB, Ban Y, Dephoure N, Hendrickson RC, et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun. 2021;12:7311.","journal-title":"Nat Commun"},{"key":"4241_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","volume":"144","author":"J Sotelo","year":"2006","unstructured":"Sotelo J, Brice\u00f1o E, L\u00f3pez-Gonz\u00e1lez MA. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2006;144:337\u201343.","journal-title":"Ann Intern Med"},{"key":"4241_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-pathmechdis-051022-014433","volume":"19","author":"N Kayagaki","year":"2024","unstructured":"Kayagaki N, Webster JD, Newton K. Control of cell death in health and disease. Annu Rev Pathol. 2024;19:157\u201380.","journal-title":"Annu Rev Pathol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04241-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:03:41Z","timestamp":1773662621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4241"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04241-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}